Today, I'm joined by Ariana Thacker, founder and CEO of MoldCo.

Born from personal experience, the company is revolutionizing treatment for mold-related illness by combining specialized testing, personalized protocols, and ongoing R&D.

In this episode, we discuss building a healthcare platform for mold toxicity.

We also cover:

• Mold exposure’s impact on 30–40M Americans
• Making the “Shoemaker Protocol” treatment more accessible
• Building a company that bridges care delivery with cutting-edge research

Subscribe to the podcast → insider.fitt.co/podcast
Subscribe to our newsletter → insider.fitt.co/subscribe
Follow us on LinkedIn → linkedin.com/company/fittinsider

Website: https://www.moldco.com/

IG: https://www.instagram.com/themoldcompany/

-

The Fitt Insider Podcast is brought to you by EGYM. Visit EGYM.com to learn more about its smart workout solutions for fitness and health facilities.

Fitt Talent: https://talent.fitt.co/

Consulting: https://consulting.fitt.co/

Investments: https://capital.fitt.co/

Chapters:
(00:00) Introduction
(01:40) Ariana’s journey to MoldCo
(03:20) Identifying mold exposure
(04:40) The prevalence of mold issues in homes and buildings
(06:00) Understanding mold toxicity symptoms and biomarkers
(07:40) The broken healthcare journey for mold patients
(10:20) Finding evidence-based solutions with the Shoemaker protocol
(12:40) Market size and impact
(14:40) From VC to founder
(18:20) Raising capital for an unconventional healthcare startup
(21:20) Growing mainstream awareness of environmental toxins
(23:20) Pioneering the standard of care for mold toxicity
(25:40) Using existing medications versus developing new treatments
(29:40) Expanding beyond mold
(32:00) Current operations and patient experience
(35:00) Nationwide expansion plans
(36:00) Making lab testing affordable and accessible
(37:40) Conclusion

281. Ariana Thacker, Founder & CEO of MoldCo

Fitt Insider